We are live on
!
Find out more
QCM
Quantinno Capital Management Portfolio holdings
AUM
$83.3B
1-Year Est. Return
37.97%
This Fund
S&P 500
This Quarter
Est. Return
+22.01%
1 Year Est. Return
+37.97%
3 Year Est. Return
+119.21%
5 Year Est. Return
+172.12%
10 Year Est. Return
–
AUM
$83.3B
AUM Growth
+$23.4B
(+39%)
Cap. Flow
+$14.4B
Cap. Flow
% of AUM
17.33%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
3,531
New
234
Increased
2,563
Reduced
581
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$792M |
| 2 |
Apple
AAPL
|
+$635M |
| 3 |
Amazon
AMZN
|
+$353M |
| 4 |
Microsoft
MSFT
|
+$275M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$245M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ingredion
INGR
|
+$77M |
| 2 |
Comcast
CMCSA
|
+$55.9M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$53M |
| 4 |
HOLX
Hologic
HOLX
|
+$43.9M |
| 5 |
A.O. Smith
AOS
|
+$38.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.06% |
| 2 | Financials | 12.42% |
| 3 | Industrials | 10.68% |
| 4 | Consumer Discretionary | 9.94% |
| 5 | Healthcare | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Rigel Pharmaceuticals
RIGL
$856M
| $802K | ﹤0.01% |
20,504
+7,537
| +58% | +$232K |
|
2727
Innovator US Equity Power Buffer ETF November
PNOV
$889M
| $802K | ﹤0.01% |
+18,082
| New | +$786K |
|
2728
Abercrombie & Fitch
ANF
$5.88B
| $802K | ﹤0.01% |
8,904
+3,732
| +72% | +$317K |
|
2729
Nurix Therapeutics
NRIX
$2.65B
| $801K | ﹤0.01% |
32,998
+10,865
| +49% | +$185K |
|
2730
Mineralys Therapeutics
MLYS
$2.47B
| $799K | ﹤0.01% |
29,629
+9,088
| +44% | +$249K |
|
2731
First Trust Cloud Computing ETF
SKYY
$3.4B
| $797K | ﹤0.01% |
5,925
+355
| +6% | +$45.1K |
|
2732
Omeros
OMER
$1.34B
| $797K | ﹤0.01% |
83,786
+22,245
| +36% | +$265K |
|
2733
Adtran
ADTN
$579M
| $794K | ﹤0.01% |
57,125
+4,670
| +9% | +$72.9K |
|
2734
Beam Therapeutics
BEAM
$2.55B
| $792K | ﹤0.01% |
23,083
+7,007
| +44% | +$212K |
|
2735
Freedom 100 Emerging Markets ETF
FRDM
$3.52B
| $791K | ﹤0.01% |
+10,849
| New | +$725K |
|
2736
JPMorgan International Value ETF
JIVE
$4B
| $786K | ﹤0.01% |
8,547
+2,897
| +51% | +$264K |
|
2737
UFP Technologies
UFPT
$2.13B
| $783K | ﹤0.01% |
2,954
+616
| +26% | +$134K |
|
2738
First Trust NASDAQ Cybersecurity ETF
CIBR
$16.5B
| $783K | ﹤0.01% |
8,709
+4,705
| +118% | +$361K |
|
|
LENZ
2739
LENZ Therapeutics
LENZ
$130M
| $782K | ﹤0.01% |
137,715
+90,067
| +189% | +$726K |
|
2740
Gentherm
THRM
$1.16B
| $779K | ﹤0.01% |
22,826
+2,926
| +15% | +$94.2K |
|
|
KRMN
2741
Karman Holdings
KRMN
$4.67B
| $778K | ﹤0.01% |
15,579
-4,173
| -21% | -$270K |
|
2742
Alpha Architect US Quantitative Value ETF
QVAL
$622M
| $777K | ﹤0.01% |
14,020
+1,659
| +13% | +$90.6K |
|
2743
ProShares Ultra QQQ
QLD
$14.2B
| $777K | ﹤0.01% |
+8,031
| New | +$691K |
|
|
BRSP
2744
BrightSpire Capital
BRSP
$529M
| $774K | ﹤0.01% |
142,094
+21,062
| +17% | +$121K |
|
2745
Vanguard Russell 2000 Growth ETF
VTWG
$1.46B
| $774K | ﹤0.01% |
2,689
+805
| +43% | +$214K |
|
2746
4D Molecular Therapeutics
FDMT
$811M
| $772K | ﹤0.01% |
58,082
+14,557
| +33% | +$142K |
|
|
FIGR
2747
Figure Technology Solutions
FIGR
$7.56B
| $770K | ﹤0.01% |
25,086
-7,263
| -22% | -$243K |
|
2748
Terreno Realty
TRNO
$7.22B
| $770K | ﹤0.01% |
11,893
+2,655
| +29% | +$174K |
|
2749
Sunoco
SUN
$14.8B
| $770K | ﹤0.01% |
11,406
+1,915
| +20% | +$127K |
|
2750
Petrobras Class A
PBR.A
$122B
| $770K | ﹤0.01% |
52,584
+4,017
| +8% | +$70.8K |
|
Similar funds
CBU
Quantinno Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Quantinno Capital Management held 3,531 positions worth $83.3B, up 39% from $59.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Quantinno Capital Management deployed $14.4B of net new capital in Q2 2026, opening 234 new positions and adding to 2,563 existing holdings. Its largest new stake was Honeywell Aerospace: 222,049 shares worth $49.1M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Ingredion, an estimated $77M trimmed.
- Quantinno Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 222,049 shares worth $49.1M.
- Quantinno Capital Management added most to NVIDIA in Q2 2026, an estimated $792M increase.
- Quantinno Capital Management's biggest Q2 2026 reduction was Ingredion, cutting an estimated $77M.
- Quantinno Capital Management fully exited Hologic in Q2 2026, selling an estimated $43.9M.
- Quantinno Capital Management's ten largest holdings make up 22% of its $83.3B portfolio in Q2 2026.
- Quantinno Capital Management opened 234 new positions and closed 97 in Q2 2026.
- Quantinno Capital Management's portfolio value rose 39% quarter-over-quarter to $83.3B.
Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.